GCANRx Announces Initiation of Preclinical Study for Neuropsychiatric Cannabinoid Therapy
08 nov. 2021 07h50 HE
|
The Greater Cannabis Company, Inc.
BALTIMORE, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid...